Zhou Yijun, Ampon Maria R, Abramson Michael J, James Alan L, Maguire Graeme P, Wood-Baker Richard, Johns David P, Marks Guy B, Reddel Helen K, Toelle Brett G
The Woolcock Institute of Medical Research, The University of Sydney, Sydney, Australia.
Australian Centre for Airways Disease Monitoring, The Woolcock Institute of Medical Research, The University of Sydney, Sydney, Australia.
ERJ Open Res. 2023 Aug 21;9(4). doi: 10.1183/23120541.00098-2023. eCollection 2023 Jul.
Diagnosis of asthma and chronic obstructive pulmonary disease (COPD) in the community is variable, often without spirometry. Some studies report that adults with both diagnostic labels (asthma+COPD) have worse health outcomes than those with asthma or COPD only, but data for Australian adults are limited. We investigated the relationship between clinical characteristics and self-reported diagnoses of asthma, COPD and both.
We used data from the BOLD Australia study, which included randomly selected adults aged ≥40 years from six study sites. The BOLD questionnaires and spirometry test were used in all sites. Participants were grouped by self-reported diagnosis. Demographic and clinical characteristics and lung function were compared between groups.
Of the study sample (n=3522), 336 reported asthma only, 172 reported COPD only, 77 reported asthma+COPD and 2937 reported neither. Fewer than half of participants with a COPD diagnosis (with or without asthma) had airflow limitation. Participants with asthma+COPD had more respiratory symptoms and greater airflow limitation than those with either diagnosis alone. Having asthma+COPD was independently associated with a higher probability of having clinically important breathlessness (modified Medical Research Council score ≥2) than asthma only (adjusted OR 3.44, 95% CI 1.86-6.33) or COPD only (adjusted OR 3.28, 95% CI 1.69-6.39). Airflow limitation (Global Initiative for Chronic Obstructive Lung Disease 2 or higher, using post-bronchodilator forced expiratory volume in 1 s/forced vital capacity ratio <0.7) was similar between asthma only and COPD only, but twice as prevalent in asthma+COPD (adjusted OR 2.18 and 2.58, respectively).
Adults with diagnoses of asthma+COPD have a higher symptom and disease burden than those with diagnoses of asthma only or COPD only. These patients should receive regular comprehensive reviews because of the substantially increased burden of having both diagnoses.
社区中哮喘和慢性阻塞性肺疾病(COPD)的诊断存在差异,通常未进行肺功能测定。一些研究报告称,患有这两种诊断标签(哮喘+COPD)的成年人比仅患有哮喘或COPD的成年人健康状况更差,但澳大利亚成年人的数据有限。我们调查了临床特征与自我报告的哮喘、COPD及两者诊断之间的关系。
我们使用了澳大利亚BOLD研究的数据,该研究包括从六个研究地点随机选取的年龄≥40岁的成年人。所有地点均使用了BOLD问卷和肺功能测定测试。参与者按自我报告的诊断进行分组。比较各组的人口统计学和临床特征以及肺功能。
在研究样本(n = 3522)中,336人仅报告患有哮喘,172人仅报告患有COPD,77人报告患有哮喘+COPD,2937人两者均未报告。诊断为COPD(无论是否合并哮喘)的参与者中,不到一半存在气流受限。与仅患有其中一种诊断的参与者相比,患有哮喘+COPD的参与者有更多的呼吸道症状和更严重的气流受限。与仅患有哮喘(调整后的OR为3.44,95%CI为1.86 - 6.33)或仅患有COPD(调整后的OR为3.28,95%CI为1.69 - 6.39)相比,患有哮喘+COPD与具有临床上重要的呼吸困难(改良医学研究委员会评分≥2)的较高概率独立相关。气流受限(慢性阻塞性肺疾病全球倡议2级或更高,使用支气管扩张剂后1秒用力呼气容积/用力肺活量比值<0.7)在仅患有哮喘和仅患有COPD的患者中相似,但在哮喘+COPD患者中的患病率是前者的两倍(调整后的OR分别为2.18和2.58)。
诊断为哮喘+COPD的成年人比仅诊断为哮喘或仅诊断为COPD的成年人有更高的症状和疾病负担。由于同时患有这两种诊断的负担大幅增加,这些患者应接受定期的全面评估。